These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

777 related items for PubMed ID: 35287543

  • 1. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer.
    Chang F, Li J, Sun Q, Wei S, Song Y.
    Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543
    [Abstract] [Full Text] [Related]

  • 2. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
    Feng N, Guo Z, Wu X, Tian Y, Li Y, Geng Y, Yu Y.
    Respir Res; 2021 Sep 18; 22(1):248. PubMed ID: 34537072
    [Abstract] [Full Text] [Related]

  • 3. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).
    Wei D, Zeng J, Rong F, Xu Y, Wei R, Zou C.
    Bioengineered; 2022 Mar 18; 13(3):5126-5140. PubMed ID: 35170372
    [Abstract] [Full Text] [Related]

  • 4. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
    Liu X, Zhou X, Chen Y, Huang Y, He J, Luo H.
    Neoplasma; 2020 Jan 18; 67(1):147-157. PubMed ID: 31686523
    [Abstract] [Full Text] [Related]

  • 5. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer.
    Pang J, Ye L, Zhao D, Zhao D, Chen Q.
    Cell Biol Int; 2020 Dec 18; 44(12):2416-2426. PubMed ID: 32808744
    [Abstract] [Full Text] [Related]

  • 6. Circ_0004015 silencing represses cisplatin chemoresistance and tumor progression by reducing KLF8 in a miR-198-dependent manner in non-small cell lung cancer.
    Li Y, Yang X, Xiong X.
    Genomics; 2022 Mar 18; 114(2):110294. PubMed ID: 35134495
    [Abstract] [Full Text] [Related]

  • 7. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
    Dong Y, Xu T, Zhong S, Wang B, Zhang H, Wang X, Wang P, Li G, Yang S.
    Life Sci; 2019 Dec 15; 239():116984. PubMed ID: 31647948
    [Abstract] [Full Text] [Related]

  • 8. Circular RNAcirc_0076305 Promotes Cisplatin (DDP) Resistance of Non-Small Cell Lung Cancer Cells by Regulating ABCC1 Through miR-186-5p.
    Wang X, Wang H, Jiang H, Qiao L, Guo C.
    Cancer Biother Radiopharm; 2023 Jun 15; 38(5):293-304. PubMed ID: 34339285
    [Abstract] [Full Text] [Related]

  • 9. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y, Zhao L, Li Q, Xi C, Li Y, Li Z.
    Thorac Cancer; 2020 Aug 15; 11(8):2196-2208. PubMed ID: 32602212
    [Abstract] [Full Text] [Related]

  • 10. Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis.
    Liu Y, Zhai R, Hu S, Liu J.
    Anticancer Drugs; 2022 Jan 01; 33(1):e186-e197. PubMed ID: 34387608
    [Abstract] [Full Text] [Related]

  • 11. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
    Xie H, Yao J, Wang Y, Ni B.
    Drug Deliv; 2022 Dec 01; 29(1):1257-1271. PubMed ID: 35467477
    [Abstract] [Full Text] [Related]

  • 12. Circ_0030998 Restrains Cisplatin Resistance Through Mediating miR-1323/PDCD4 Axis in Non-small Cell Lung Cancer.
    Zhu C, Jiang X, Xiao H, Guan J.
    Biochem Genet; 2022 Dec 01; 60(6):2434-2454. PubMed ID: 35460386
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    Cheng J, Zhang R, Yan M, Li Y.
    BMC Cancer; 2022 Mar 04; 22(1):238. PubMed ID: 35241028
    [Abstract] [Full Text] [Related]

  • 15. Circ_0110498 facilitates the cisplatin resistance of non-small cell lung cancer by mediating the miR-1287-5p/RBBP4 axis.
    Hao D, Li Y, Shi J, Jiang J.
    Thorac Cancer; 2023 Mar 04; 14(7):662-672. PubMed ID: 36691322
    [Abstract] [Full Text] [Related]

  • 16. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P, Cao L, Zheng M, Yao Y, Wang W, Chen X.
    Exp Mol Pathol; 2021 Jun 04; 120():104633. PubMed ID: 33753110
    [Abstract] [Full Text] [Related]

  • 17. Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis.
    Zheng S, Wang C, Yan H, Du Y.
    Bioengineered; 2021 Dec 04; 12(1):8347-8357. PubMed ID: 34592879
    [Abstract] [Full Text] [Related]

  • 18. Circular RNA circ_0005667 promotes cisplatin resistance of endometrial carcinoma cells by regulating IGF2BP1 through miR-145-5p.
    Sun G, Tian J, Xiao Y, Zeng Y.
    Anticancer Drugs; 2023 Aug 01; 34(7):816-826. PubMed ID: 36728962
    [Abstract] [Full Text] [Related]

  • 19. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis.
    Xu Y, Zhao R, Wang H, Jiang J, Wang Z, Wang J, Zhang W, Li M.
    J BUON; 2021 Aug 01; 26(5):1850-1861. PubMed ID: 34761592
    [Abstract] [Full Text] [Related]

  • 20. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
    Chang N, Ge N, Zhao Y, Yang L, Qin W, Cui Y.
    J Clin Lab Anal; 2022 May 01; 36(5):e24304. PubMed ID: 35312115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.